全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:André Luiz Muniz , Waldyr Rodrigues Jr. ...
来源:[J].Arquivos de Neuro-Psiquiatria(IF 0.827), 2006, Vol.64 (2a), pp.217-221DOAJ
摘要:OBJECTIVE: To identify clinical and immunological markers associated with HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). METHOD: 237 HTLV-I infected individuals were clinically assessed. They were classified according to the Expanded Disability Status S...
作者:André Luiz Muniz , Amélia Ribeiro de Jesus
来源:[J].Memórias do Instituto Oswaldo Cruz.(IF 1.363), 2004, Vol.99, pp.121-126DOAJ
摘要:Human T cell leukemia virus type-I (HTLV-I) infection is associated with spontaneous T cell activation and uncontrolled lymphocyte proliferation. An exacerbated type-1 immune response with production of pro-inflammatory cytokines (interferon-gamma and tumor necrosis factor-alpha)...
作者:André Luiz Muniz , Marshall J. Glesby
来源:[J].Journal of Medical Virology(IF 2.373), 2012, Vol.84 (11), pp.1809-1817Wiley
摘要:Abstract(#br)The majority of patients infected with human T‐cell lymphotropic virus‐type 1 (HTLV‐1) are considered carriers, but a high frequency of urinary symptoms of overactive bladder, common in HTLV‐1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) hav...
作者:... Lúcia Passos , André Luiz Muniz , Silvane Santos
来源:[J].Case Reports in Neurological Medicine, 2012, Vol.2012DOAJ
摘要:The human T-cell lymphotropic virus type 1 (HTLV-1) is the known causative agent of a chronic neurologic condition known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Although several therapies have been evaluated for HAM/TSP, none have been approved for...
作者:André Luiz Muniz , Silvane Santos ...
来源:[J].Case Reports in Neurological Medicine, 2012, Vol.2012Hindawi
摘要:The human T-cell lymphotropic virus type 1 (HTLV-1) is the known causative agent of a chronic neurologic condition known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Although several therapies have been evaluated for HAM/TSP, none have been approved for...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×